ArticleJournal of molecular and cellular cardiology plus2026
CardioPharmaGENET (CA24165): A COST action network for advancing cardiovascular pharmacogenomics and precision medicine.
Adna Ašić et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.